21st Century Fox (FOX) has increased its bid for Sky plc (SKY) to $32.5 billion. Fox’s price is at a 12% premium to Comcast’s (CMCSA) previous offer. This new offer just changed the game and all eyes are on Comcast to see if the media company will respond with a higher bid of its own or will bow out and walk away.
Although Comcast has not commented on the matter, shareholders believe there will be more bids that could take the end price well ahead of Sky’s current stock price. The final purchase price would depend on how far a company would go before its shareholders decide to drop the pursuit. Depending on how valuable or strategically beneficial an asset is, companies can end up paying hefty sums.
RELATED: Comcast could again make a move for Fox, but will Disney let go?
In another tussle, Comcast and Walt Disney (DIS) are looking to buy Fox and a stake in Sky will come with it. Disney has already secured regulatory approval for this deal and it is likely that Comcast would want to at least get hold of Sky. This is not surprising because with its broad presence in Europe, Sky is a valuable asset and its shareholders believe it can fetch a higher price than what has been offered by Fox right now.
Meanwhile, a Fox shareholder has filed a lawsuit against the Fox-Disney transaction asking for more financial information before important decisions can be made.
RELATED: Will Apple and Google top Disney’s $71-billion bid for FOX?
Streaming service providers like Netflix (NFLX) are turning out to be forces to reckon with and top media and telecom companies are trying hard to stay competent. Buying lucrative assets and striking strategic deals are part of these efforts. Elsewhere AT&T (T) is pushing for hard changes at its HBO network to increase engagement and better compete with Netflix.
Some analysts also believe that it wouldn’t be such a bad thing if Comcast did not acquire either company, considering the financial burden that would come with it. The twists in this story keep coming and Wall Street can expect some more interesting turns before a final decision is made.
Most Popular
Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO
Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training
INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues
Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came
Riding the AI wave, Nvidia looks set to stay on the high-growth path
After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on